Objective To evaluate the Vitamin D nutritional status in male patient with type 2 diabetes (T2DM) and its effects on bone markers. Methods 258 cases of male patients with T2DM were recruited, their serum levels of 25-hydroxyvitamin D[25(OH)D], tPINP and β-CTX were measured by Roche E170 automatic electrochemiluminescence immunoassay analyzer. According to 25(OH)D levels, patients were divided into 4 groups: severe deficiency (<25 nmol/L) , deficiency (≥25 nmol/L and <50 nmol/L) , insufficiency (≥50 nmol/L and <75 nmol/L) and sufficiency (≥75 nmol/L) groups. Results The total 25(OH)D level in T2DM patients was 33.80±18.43 nmol/L,which indicated vitamin D deficiency.The participants were divided into 4 age groups, middle-aged group (35-49 year old), presenium group (50-59 year old), gerontism group 1 (60-69 year old), gerontism group 2 (>70 year old). As the increase of age, the concentration of 25(OH)D decreased gradually. The 25 (OH) D levels in gerontism group 2 was significantly lower than that of middle-aged group, but bone markers had no significant difference among various age groups. The proportion of vitamin D in severe dificiency,defiency,insufficiency and sufficiency groups were 36.43%(94/258), 48.45%(125/258), 11.63%(30/258) and 3.49%(9/258)respectively. The level of β-CTX in severe deficiency group was apparently higher than other groups (P<0.05). tPINP had no difference between various nutritional status groups. The level of serum 25(OH)D was negatively correlated with serum β-CTX (r=-0.197,P=0.001), however 25(OH)D had no relevance with tPINP(r=-0.046,P=0.464). Conclusion Vitamin D severe deficiency and insufficiency are highly prevalent among male patient with type 2 diabetes.There is no evidence shows that the serum 25(OH)D severe deficiency is associated with bone formation, while the bone absorption increases.
QU Wei,LIN Yan-li,LI Yan,LIU Chun-yan,ZHANG Rui-sheng
. Vitamin D Nutritional Status in Male Patient with Type 2 Diabetes (T2DM) and Its Effects on Bone Turnover Markers[J]. Labeled Immunoassays and Clinical Medicine, 2015
, 22(3)
: 161
.
DOI: 10.11748/bjmy.issn.1006-1703.2015.03.001